menu search

Why is enveric biosciences (envb) stock up 120% today?

Enveric Biosciences (NASDAQ: ENVB ) stock is enlivened amid an otherwise soft early afternoon session on Wall Street, delivering triple-digit percenta...

May 18, 2023, 3:06 pm

Telesis bio announces first commercial shipment of bioxp® ngs library prep kit

New Kit Enables Automation of NGS Library Prep on the BioXp® System Further Expanding the Utility, Speed, and Impact of the BioXp® Automated ...

May 18, 2023, 2:00 pm

molecular partners to participate in rbc capital 2023 global healthcare conference

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., May 16, 2023 (GLOBE NEWSWIRE) -- molecular Partners A...

May 16, 2023, 4:00 pm

Exact sciences positioned for a solid year after ‘impressive' 1q, broker says

Exact Sciences (NASDAQ:EXAS) Corporation earned a price target raise from Canaccord Genuity (TSX:CF, LSE:CF) after the ...

May 16, 2023, 2:43 pm

Precision medicine market size to surpass usd 126.24 billion by 2030 at 12.50% cagr – report by market research future (mrfr)

Precision Medicine Market Trends And Insights By Ecosystem Players (Pharmaceuticals and Biotechnology Companies, Diagnostic Companies, Healthcare IT S...

May 16, 2023, 2:30 pm

Grimes and bitcoin: how crypto and the open-source movement offer lessons for the music industry in the age of a.i.

In response, Universal Music Group, which represents the musicians, issued an agitated statement, and then, as the song turned up on other platforms, ...

May 14, 2023, 2:44 pm

Andreas halvorsen's firm packs further into 4d molecular therapeutics

Viking Global Investors LP, the firm managed by Andreas Halvorsen (Trades, Portfolio), disclosed in a regulatory filing that it boosted its holding in...

May 12, 2023, 5:57 pm

Monte rosa therapeutics announces first quarter 2023 financial results and provides corporate update

On track to present initial data from Phase 1/2 clinical trial of MRT-2359 in MYC-driven solid tumors in the second half of 2023 Cash runway into 2025...

May 11, 2023, 11:30 am

moleculin biotech, inc. (mbrx) q1 2023 earnings call transcript

moleculin Biotech, Inc. (NASDAQ:MBRX ) Q1 2023 Earnings Conference Call May 11, 2023 8:30 AM ET Company...

May 11, 2023, 11:29 am

Mbrx stock earnings: moleculin biotech misses eps estimates

moleculin Biotech (NASDAQ: MBRX ) reported first quarter results for 2023. ...

May 11, 2023, 8:04 am

Htg molecular diagnostics reports first quarter 2023 results and provides recent business highlights

TUCSON, Ariz., May 10, 2023 (GLOBE NEWSWIRE) — HTG molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), ...

May 10, 2023, 9:51 pm

As covid public health emergency ends, ‘whack-a-mole' virus won't be easy to track

As the U.S. COVID-19 public health emergency comes to an end on Thursday, the fight against COVID goes on–-and some new challenges begin for those w...

May 10, 2023, 2:30 pm

Immunic, inc. to announce financial results for the first quarter ended march 31, 2023, and provide corporate update

– Webcast to be Held at 8:00 am ET on May 11, 2023 – NEW YORK , May 9, 2023 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology compan...

May 9, 2023, 6:30 am

molekule group, inc. announces closing of $10.0 million private placement and deferral of $6.0 million principal amortization through 2025

PALM BEACH GARDENS, Fla., May 08, 2023 (GLOBE NEWSWIRE) — molekule Group, Inc. (“...

May 8, 2023, 11:30 pm

Immunic presents data showing beneficial effects of imu-856 on gut health at digestive disease week 2023

Immunic Inc (NASDAQ:IMUX) said it has presented new clinical and pre-clinical data on the molecule IMU-...

May 8, 2023, 8:17 am

4d molecular therapeutics, inc. (fdmt) surges 5.4%: is this an indication of further gains?

4D molecular Therapeutics, Inc. (FDMT) saw its shares surge in the last session with trading volume bei...

May 8, 2023, 7:39 am

Prothena biosciences' unique approach to protein misfolding could be the future

Prothena's recent collaboration with Walgreens is expected to drive recruitment for Prothena's ongoing ASCENT-2 safety and tolerability trial of PRX01...

May 7, 2023, 2:28 am

4d molecular therapeutics announces pricing of upsized public offering of common stock

EMERYVILLE, Calif., May 04, 2023 (GLOBE NEWSWIRE) — 4D molecular Therapeutics, Inc. (Nasdaq: FDMT), a...

May 5, 2023, 1:04 am

moleculin to report first quarter financial results on may 11, 2023 and host conference call and webcast

HOUSTON , May 4, 2023 /PRNewswire/ -- moleculin Biotech, Inc., (Nasdaq: MBRX) ("...

May 4, 2023, 8:35 am

Societal cdmo to report financial results for first quarter 2023 on may 10, 2023

Webcast Scheduled for Wednesday, May 10, 2023, at 4:30 p.m. Eastern SAN DIEGO and GAINESVILLE, Ga., May 03, 2023 (GLOBE NEWSWIRE) — Societal CDMO, I...

May 3, 2023, 8:05 pm


Search within

Pages Search Results: